Free Delivery Over $100
|
|
|||
|
||||
OverviewAlzheimer’s disease is the most prevalent form of dementia. Although it was discovered about a century ago, the first drugs applied in treatment were only introduced in therapy in the last 30 years. This book focuses on the clinical pharmacology of drugs that aim to delay the progression of Alzheimer’s disease, such as anticholinesterases and glutamate receptor antagonists, as well as treatment for the behavioral changes caused by the progression of the disease: antidepressants, antipsychotics, anxiolytics, and mood stabilizers. In addition, it describes important information about the pathophysiology and diagnostic methods of Alzheimer’s disease, emergency situations conditioned by the dementia process, and presents new perspectives for the treatment of Alzheimer’s disease. The ten chapters cover topics such as mechanism of action, dosage regimen, adverse reactions, drug interactions, toxicity profiles, among other information of clinical relevance. The work comprises evidence-based studies, providing a valuable resource for analyzing, prescribing and monitoring patients being treated for Alzheimer’s disease. Written by experts with solid professional experience, this book will appeal to pharmacologists, geriatricians, neurologists, psychiatrists, biomedical clinicians, and other healthcare professionals. Full Product DetailsAuthor: Gustavo Alves Andrade dos SantosPublisher: Springer Nature Switzerland AG Imprint: Springer Nature Switzerland AG Edition: 1st ed. 2022 Weight: 0.471kg ISBN: 9783030943851ISBN 10: 3030943852 Pages: 231 Publication Date: 30 March 2023 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand  We will order this item for you from a manufactured on demand supplier. Table of Contents1. IntroductionGustavo Alves Andrade dos Santos 2. Principles of Pharmacology in DementiaFrancisco Assis Carvalho Vale, Judith Thomas Tayra, Carina Tellaroli Spedo3. The Viability of Treatment Conditioned to the Pathophysiology of Alzheimer's DiseaseFabricio Ferreira de Oliveira4. The Use of Esterase InhibitorsGustavo Alves Andrade dos Santos, Carolina Witchmichen Penteado Schmidt, Karina Pedrotti Forlenza5. Pharmacology of NMDA (N-methyl-D-aspartate) receptor antagonists in Alzheimer’s DiseaseCarolina Witchmichen Penteado Schmidt 6. Supportive Pharmacological TreatmentKaléu Mormino Otoni, Karla Bruna Nogueira Torres Mormino, Sandna Larissa Freitas dos Santos, Maria Liliane Luciano Pereira7. Herbal Medicines and SupplementsEduardo Caritá 8. Emergency SituationsMilena Carvalho Libardi, GuilhermeRiccioppo Rodrigues, Rui Kleber Martins Filho9. Relationships between Treatment and Clinical EvaluationsPaulo Pardi, Gustavo Alves Andrade dos Santos10. New Perspectives for Treatment in Alzheimer's DiseaseJúlia Cunha Loureiro, Marcos Vasconcelos Pais, Luiz Fernando de Almeida Lima e Silva, Orestes Vicente ForlenzaReviewsAuthor InformationGustavo Alves Andrade dos Santos is Pharmacist-Biochemist, holds a PhD in Biotechnology, Master's degree in Pharmacy and a Post Doctorate in Anatomy and Surgery from the University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil. He also studied Neurobiology at the University of Chicago, Clinical Pharmacy at University Central of Florida, USA; Hospital Pharmacy, Necker Hospital in Paris, France, and completed a post-graduation in Hospital Pharmacy, Oswaldo Cruz Faculty, São Paulo, Brazil. Dr. Santos is currently a Professor at the Faculty of Medicine São Leopoldo Mandic, Araras, São Paulo, Brazil and Oswaldo Cruz Faculty, São Paulo, Brazil; coordinator of the technical group of pharmaceutical care to the elderly of the Regional Pharmacy Council of the State of São Paulo. He is member of the International Society of the Alzheimer's Association to promote research and treatment of Alzheimer's disease (ISTAART) and member of the American Society of Health System Pharmacists (ASHP). Tab Content 6Author Website:Countries AvailableAll regions |
||||
